Dietary Supplement M&A Diligence: Claims, Manufacturing, Quality, and Revenue Risk
A buyer-underwriting-focused guide to dietary supplement M&A diligence, including claims substantiation, label and marketing review, cGMP and manufacturing controls, co-manufacturer risk, quality systems, COAs, testing records, complaints, adverse events, recalls, revenue quality, channel economics, inventory, working capital, escrows, indemnities, earnouts, and closing certainty.